OPHTHALMIC RADIATION THERAPY

Ophthalmic Radiation Therapy

Ophthalmic radiation therapy is an important therapeutic modality in the management of a variety of ocular and periocular diseases, particularly malignant and selected benign conditions. By delivering controlled doses of ionizing radiation to targeted ocular tissues, radiation therapy can effectively destroy abnormal cells while preserving surrounding healthy structures and visual function. Advances in radiation physics, imaging, and treatment planning have significantly improved the safety and precision of ophthalmic radiation therapy, making it an integral part of modern ocular oncology and subspecialty ophthalmology.

Principles of Radiation Therapy in Ophthalmology

Radiation therapy works by damaging the DNA of rapidly dividing cells, leading to cell death or loss of reproductive capacity. In ophthalmology, radiation must be delivered with extreme precision due to the eye’s delicate anatomy and radiosensitive structures such as the lens, optic nerve, retina, and lacrimal gland. The primary goal is to achieve maximal tumor control with minimal radiation-related toxicity.

Treatment planning involves detailed imaging, including ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), to define tumor size, location, and proximity to critical structures. Customized treatment plans ensure accurate dose delivery and optimal outcomes.

Indications for Ophthalmic Radiation Therapy

Ophthalmic radiation therapy is most commonly used in ocular oncology, particularly for intraocular tumors. The most frequent indication is uveal melanoma, where radiation therapy serves as an eye-preserving alternative to enucleation. Other malignant conditions treated with radiation include retinoblastoma, conjunctival lymphoma, orbital lymphoma, and metastatic tumors to the eye or orbit.

In addition to malignancies, radiation therapy may be used for selected benign conditions such as aggressive hemangiomas, inflammatory orbital pseudotumors, and thyroid eye disease when conventional therapies fail.

Radiation Modalities

Several radiation modalities are employed in ophthalmic practice, each with specific advantages.

Plaque brachytherapy is widely used for intraocular tumors, particularly uveal melanoma. Radioactive plaques containing isotopes such as iodine-125 or ruthenium-106 are surgically placed on the sclera overlying the tumor, delivering localized radiation while sparing surrounding tissues.

Proton beam therapy offers highly precise dose delivery due to the Bragg peak phenomenon, which allows radiation to stop at a predetermined depth. This modality is especially useful for tumors near critical structures, such as the optic nerve or macula.

External beam radiation therapy, including stereotactic radiotherapy and intensity-modulated radiation therapy (IMRT), is commonly used for orbital tumors and lymphomas. These techniques allow conformal dose distribution and reduced exposure to normal tissues.

Radiation Therapy in Retinoblastoma

In retinoblastoma, radiation therapy plays a role in selected cases where chemotherapy and focal treatments are insufficient. Modern approaches aim to minimize radiation exposure due to the risk of secondary malignancies, particularly in children with germline mutations. When used, highly targeted techniques are employed to reduce long-term complications.

Complications and Side Effects

Despite technological advances, ophthalmic radiation therapy carries potential risks. Radiation retinopathy, optic neuropathy, cataract formation, dry eye, and neovascular glaucoma are among the most common complications. The likelihood and severity of side effects depend on radiation dose, treatment modality, tumor location, and patient-specific factors.

Early detection and management of radiation-induced complications are essential. Adjunctive treatments such as anti-VEGF therapy have improved the management of radiation retinopathy and macular edema.

Follow-Up and Outcomes

Long-term follow-up is critical for assessing tumor control, visual outcomes, and late radiation effects. In many cases, ophthalmic radiation therapy achieves excellent local tumor control and eye preservation. Visual outcomes vary depending on tumor location and treatment-related complications.

Conclusion

Ophthalmic radiation therapy is a highly specialized and effective treatment modality that plays a crucial role in the management of ocular and orbital diseases. With continued advances in technology and multidisciplinary collaboration, radiation therapy continues to offer vision-preserving solutions for patients with complex ophthalmic conditions.